Jones Day represented Stallergenes Greer plc, a global biopharmaceutical company specializing in treatments for respiratory allergies, in connection with a new revolving credit facility provided by UBS Switzerland AG.

For additional information about this matter, please contact: Linda A. Hesse, Paul Simcock, John D. Casais
Client(s): Stallergenes Greer plc
Practice(s): Banking & Finance
Office(s): Boston, London, Paris, Cleveland